질환 관리 앱 시장 규모, 점유율, 동향 분석 보고서 : 플랫폼 유형별(iOS, Android), 디바이스별, 적응증별, 지역별, 부문별 예측(2023-2030년)

Disease Management Apps Market Growth & Trends:

The global disease management apps market size is expected to reach USD 22.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.3% from 2023 to 2030. The rising consumer demand to monitor their health and growing trend of prioritizing a healthy lifestyle are anticipated to drive global disease management apps market. Moreover, increasing smartphone and internet penetration and surging trend of preventive healthcare are also expected to propel market at certain extent. Also, the COVID-19 pandemic has significantly boosted the demand for health applications, and diseases management applications to track disease symptoms and health.

Moreover, the rising consumer awareness about health risks associated with poor nutrition is bolstering the demand for disease management apps. Some of the common disease management apps are, Medisafe, Sleep Cycle and others. According to the study conducted by World Economic Forum in September 2020, the demand for fitness and disease tracking apps increased by 46% in terms of downloads and is projected to grow more as people started using smart band, wearables on large extent.

In addition, the emergence of novel technologies and flourishing demand for diseases management apps with other parameters tracking has driven the market at rapid pace. Moreover, increasing initiatives by market participants to develop enhanced applications owing to their escalated demand is further fueling market's uptake. For instance, in February 2021, Takeda Pharmaceuticals Limited launched an application for the management of patients with rare lysosomal storage disorder. This newly launched application is expected to overcome challenges in managing lysosomal storage disease.

Furthermore, the aging population, hybrid lifestyle, and rise in alcohol consumption are contributing to long term health conditions thereby fueling the demand for health tracking applications. In addition, rapid urbanization, technological advancements in mhealth space and addon features of disease management apps like medication reminders, symptom tracking, and remote consultation features are anticipated to facilitate uptake of these applications over the forecast period.

Disease Management Apps Market Report Highlights:

• The smartphones segment held the largest share of 50.8% in 2022 owing to constant product developments in terms of features and functions, and rising inclination for fitness tracking and health monitoring

• The wearables segment is anticipated to register the fastest growth rate because of increased adoption of wearable products among consumers and increased efforts from market players to introduce wearables with advanced monitoring features

• The android segment accounted for the largest market share of 51.8% in 2022 due to increasing penetration of android-based products in developed as well as developing economies, increasing demand for smart medical devices incorporated with health apps, and higher standards of privacy and curated content in the platforms

• Asia Pacific is expected to exhibit the fastest growth over the forecast period due to various government initiatives to promote uptake of mhealth and other disease management applications

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Competitive Insights

Chapter 3 Disease Management Apps Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market
• 3.2 Market Dynamics
  • 3.2.1 Market drivers analysis
    • 3.2.1.1 Increasing trend for healthy lifestyle
    • 3.2.1.2 Technological advancements and smartphone penetration
    • 3.2.1.3 Increasing prevalence of target diseases
    • 3.2.1.4 Strategic initiatives undertaken by leading participants
  • 3.2.2 Market restraint analysis
    • 3.2.2.1 Concerns about data safety and security
• 3.3 Disease Management Apps: Market Analysis Tools
  • 3.3.1 Industry analysis - Porter's
  • 3.3.2 PESTLE analysis
• 3.4 Regulatory Framework

Chapter 4 Disease Management Apps Market Segment Analysis, By Platform Type, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Platform type Market Share Analysis, 2022 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Disease Management Apps Market, by Platform type, 2018 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.5.1 iOS
    • 4.5.1.1 iOS market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.2 Android
    • 4.5.2.1 Android market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.3 Others
    • 4.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Disease Management Apps Market Segment Analysis, By Device 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Device Market Share Analysis, 2022 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Disease Management Apps Market, by Device, 2018 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5.1 Smartphones
    • 5.5.1.1 Smartphones market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.2 Tablets
    • 5.5.2.1 Tabletes estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.3 Wearables
    • 5.5.3.1 Wearables estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Disease Management Apps Market Segment Analysis, By Indication, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 Indication Market Share Analysis, 2022 & 2030
• 6.3 Segment Dashboard
• 6.4 Global Disease Management Apps Market, by Indication, 2018 to 2030
• 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.5.1 Obesity
    • 6.5.1.1 Obesity market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.2 Cardiovascular issues
    • 6.5.2.1 Cardiovascular issues market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3 Diabetes
    • 6.5.3.1 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.4 Mental Health
    • 6.5.4.1 Mental health market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.5 Others
    • 6.5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Disease Management Apps Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 7.1 Definition & Scope
• 7.2 Regional Market Share Analysis, 2022 & 2030
• 7.3 Regional Market Dashboard
• 7.4 Regional Market Snapshot
• 7.5 SWOT Analysis
  • 7.5.1 North America
  • 7.5.2 Europe
  • 7.5.3 Asia Pacific
  • 7.5.4 Latin America
  • 7.5.5 Middle East & Africa
• 7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
  • 7.6.1 North America
    • 7.6.1.1 North America disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.1.2 U.S.
    • 7.6.1.2.1 Key Country Dynamics
    • 7.6.1.2.2 Competitive Scenario
    • 7.6.1.2.3 Regulatory Framework
    • 7.6.1.2.4 Reimbursement Scenario
    • 7.6.1.2.5 U.S. disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.1.3 Canada
    • 7.6.1.3.1 Key Country Dynamics
    • 7.6.1.3.2 Competitive Scenario
    • 7.6.1.3.3 Regulatory Framework
    • 7.6.1.3.4 Reimbursement Scenario
    • 7.6.1.3.5 Canada disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.2 Europe
    • 7.6.2.1 Europe disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.2 UK
    • 7.6.2.2.1 Key Country Dynamics
    • 7.6.2.2.2 Competitive Scenario
    • 7.6.2.2.3 Regulatory Framework
    • 7.6.2.2.4 Reimbursement Scenario
    • 7.6.2.2.5 UK disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.3 Germany
    • 7.6.2.3.1 Key Country Dynamics
    • 7.6.2.3.2 Competitive Scenario
    • 7.6.2.3.3 Regulatory Framework
    • 7.6.2.23.4 Reimbursement Scenario
    • 7.6.2.3.5 Germany disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.4 Spain
    • 7.6.2.4.1 Key Country Dynamics
    • 7.6.2.4.2 Competitive Scenario
    • 7.6.2.4.3 Regulatory Framework
    • 7.6.2.4.4 Reimbursement Scenario
    • 7.6.2.4.5 Spain disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.5 France
    • 7.6.2.5.1 Key Country Dynamics
    • 7.6.2.5.2 Competitive Scenario
    • 7.6.2.5.3 Regulatory Framework
    • 7.6.2.5.4 Reimbursement Scenario
    • 7.6.2.5.5 France disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.6 Italy
    • 7.6.2.6.1 Key Country Dynamics
    • 7.6.2.6.2 Competitive Scenario
    • 7.6.2.6.3 Regulatory Framework
    • 7.6.2.6.4 Reimbursement Scenario
    • 7.6.2.6.5 Italy disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.7 Denmark
    • 7.6.2.7.1 Key Country Dynamics
    • 7.6.2.7.2 Competitive Scenario
    • 7.6.2.7.3 Regulatory Framework
    • 7.6.2.7.4 Reimbursement Scenario
    • 7.6.2.7.5 Denmark disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.8 Norway
    • 7.6.2.8.1 Key Country Dynamics
    • 7.6.2.8.2 Competitive Scenario
    • 7.6.2.8.3 Regulatory Framework
    • 7.6.2.8.4 Reimbursement Scenario
    • 7.6.2.8.5 Norway disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2.9 Sweden
    • 7.6.2.9.1 Key Country Dynamics
    • 7.6.2.9.2 Competitive Scenario
    • 7.6.2.9.3 Regulatory Framework
    • 7.6.2.9.4 Reimbursement Scenario
    • 7.6.2.9.5 Sweden disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3 Asia Pacific
    • 7.6.3.1 Asia Pacific disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.2 Japan
    • 7.6.3.2.1 Key Country Dynamics
    • 7.6.3.2.2 Competitive Scenario
    • 7.6.3.2.3 Regulatory Framework
    • 7.6.3.2.4 Reimbursement Scenario
    • 7.6.3.2.5 Japan disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.3 China
    • 7.6.3.3.1 Key Country Dynamics
    • 7.6.3.3.2 Competitive Scenario
    • 7.6.3.3.3 Regulatory Framework
    • 7.6.3.3.4 Reimbursement Scenario
    • 7.6.3.3.5 China disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.4 India
    • 7.6.3.4.1 Key Country Dynamics
    • 7.6.3.4.2 Competitive Scenario
    • 7.6.3.4.3 Regulatory Framework
    • 7.6.3.4.4 Reimbursement Scenario
    • 7.6.3.4.5 India disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.5 South Korea
    • 7.6.3.5.1 Key Country Dynamics
    • 7.6.3.5.2 Competitive Scenario
    • 7.6.3.5.3 Regulatory Framework
    • 7.6.3.5.4 Reimbursement Scenario
    • 7.6.3.5.5 South Korea disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.6 Australia
    • 7.6.3.6.1 Key Country Dynamics
    • 7.6.3.6.2 Competitive Scenario
    • 7.6.3.6.3 Regulatory Framework
    • 7.6.3.6.4 Reimbursement Scenario
    • 7.6.3.6.5 Australia disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3.7 Singapore
    • 7.6.3.7.1 Key Country Dynamics
    • 7.6.3.7.2 Competitive Scenario
    • 7.6.3.7.3 Regulatory Framework
    • 7.6.3.7.4 Reimbursement Scenario
    • 7.6.3.7.5 Singapore disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.4 Latin America
    • 7.6.4.1 Latin America disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4.2 Brazil
    • 7.6.4.2.1 Key Country Dynamics
    • 7.6.4.2.2 Competitive Scenario
    • 7.6.4.2.3 Regulatory Framework
    • 7.6.4.2.4 Reimbursement Scenario
    • 7.6.4.2.5 Brazil disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4.3 Mexico
    • 7.6.4.3.1 Key Country Dynamics
    • 7.6.4.3.2 Competitive Scenario
    • 7.6.4.3.3 Regulatory Framework
    • 7.6.4.3.4 Reimbursement Scenario
    • 7.6.4.3.5 Mexico disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4.4 Argentina
    • 7.6.4.4.1 Key Country Dynamics
    • 7.6.4.4.2 Competitive Scenario
    • 7.6.4.4.3 Regulatory Framework
    • 7.6.4.4.4 Reimbursement Scenario
    • 7.6.4.4.5 Argentina disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.5 MEA
    • 7.6.5.1 MEA disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5.2 South Africa
    • 7.6.5.2.1 Key Country Dynamics
    • 7.6.5.2.2 Competitive Scenario
    • 7.6.5.2.3 Regulatory Framework
    • 7.6.5.2.4 Reimbursement Scenario
    • 7.6.5.2.5 South Africa disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5.3 Saudi Arabia
    • 7.6.5.3.1 Key Country Dynamics
    • 7.6.5.3.2 Competitive Scenario
    • 7.6.5.3.3 Regulatory Framework
    • 7.6.5.3.4 Reimbursement Scenario
    • 7.6.5.3.5 Saudi Arabia disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5.4 UAE
    • 7.6.5.4.1 Key Country Dynamics
    • 7.6.5.4.2 Competitive Scenario
    • 7.6.5.4.3 Regulatory Framework
    • 7.6.5.4.4 Reimbursement Scenario
    • 7.6.5.4.5 UAE disease management apps market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5.4 Kuwait
    • 7.6.5.4.1 Key Country Dynamics
    • 7.6.5.4.2 Competitive Scenario
    • 7.6.5.4.3 Regulatory Framework
    • 7.6.5.4.4 Reimbursement Scenario
    • 7.6.5.4.5 Kuwait disease management apps market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Disease Management Apps Market - Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.1.2 Heat map analysis
  • 8.1.3 Major Deals and Strategic Alliances Analysis
    • 8.1.3.1 Joint Ventures
    • 8.1.3.2 Licensing Agreements
    • 8.1.3.3 Product Launches
• 8.2 Company Categorization
  • 8.2.1 Innovators
  • 8.2.2 Market Leaders
• 8.3 Vendor Landscape
  • 8.3.1 List of key distributors and channel partners
  • 8.3.2 Key customers
• 8.4 Public Companies
  • 8.4.1 Competitive Dashboard Analysis
    • 8.4.1.1 Market Differentiators
• 8.5 Private Companies
  • 8.5.1 List of key emerging companies
• 8.6 Company Profiles
  • 8.6.1 Fitbit LLC
    • 8.6.1.1 Company overview
    • 8.6.1.2 Financial performance
    • 8.6.1.3 Product benchmarking
    • 8.6.1.4 Strategic Initiatives
  • 8.6.2 Healthy.io.Ltd
    • 8.6.2.1 Company overview
    • 8.6.2.2 Financial performance
    • 8.6.2.3 Product benchmarking
    • 8.6.2.4 Strategic Initiatives
  • 8.6.3 MyFitnessPal, Inc.
    • 8.6.3.1 Company overview
    • 8.6.3.2 Financial performance
    • 8.6.3.3 Product benchmarking
    • 8.6.3.4 Strategic Initiatives
  • 8.6.4. Noom, Inc.
    • 8.6.4.1 Company overview
    • 8.6.4.2 Financial performance
    • 8.6.4.3 Product benchmarking
    • 8.6.4.4 Strategic Initiatives
  • 8.6.5 Azumio Inc.
    • 8.6.5.1 Company overview
    • 8.6.5.2 Financial performance
    • 8.6.5.3 Product benchmarking
    • 8.6.5.4 Strategic Initiatives
  • 8.6.6 Medisafe
    • 8.6.6.1 Company overview
    • 8.6.6.2 Financial performance
    • 8.6.6.3 Product benchmarking
    • 8.6.6.4 Strategic Initiatives
  • 8.6.7 Sleep Cycle
    • 8.6.7.1 Company overview
    • 8.6.7.2 Financial performance
    • 8.6.7.3 Product benchmarking
    • 8.6.7.4 Strategic initiatives
  • 8.6.8 Curable, Inc
    • 8.6.8.1 Company overview
    • 8.6.8.2 Financial performance
    • 8.6.8.3 Product benchmarking
    • 8.6.8.4 Strategic initiatives
  • 8.6.9 Bearable Ltd
    • 8.6.9.1 Company overview
    • 8.6.9.2 Financial performance
    • 8.6.9.3 Product benchmarking
    • 8.6.9.4 Strategic initiatives
  • 8.6.10 Omada Health Inc.
    • 8.6.10.1 Company overview
    • 8.6.10.2 Financial performance
    • 8.6.10.3 Product benchmarking
    • 8.6.10.4 Strategic initiatives